newsfilter
← Latest News
PR Newswire·

MEDIVIR AB - INTERIM REPORT JANUARY - JUNE 2022

STOCKHOLM, Aug. 19, 2022 /PRNewswire/ -- The clinical development of fostrox remains the focus April - June Financial summary for the quarter Net turnover amounted to SEK 0.5 (0.9) million. The loss before interest, tax, depreciation and amor